Notes from the Field: Four Cases of Lyme Disease at an Outdoor Wilderness Camp — North Carolina, 2017 and 2019

Alexis M. Barbarin, PhD1; Steven W. Seagle, PhD2; Susan Creede3 (View author affiliations)

View suggested citation
Article Metrics
Altmetric:
Citations:
Views:

Views equals page views plus PDF downloads

Related Materials

On June 10, 2019, the North Carolina Division of Public Health was notified by the Buncombe County Health Department of three cases of Lyme disease among children aged 6–8 years. Lyme disease is a bacterial infection transmitted by the bite of an Ixodes scapularis tick that is infected most commonly with the bacterium Borrelia burgdorferi. An investigation conducted by Buncombe County communicable disease nurses determined that all three children were homeschooled and had attended a local, year-round, outdoor wilderness day camp. Each child had attended the camp at least 1 day a week over the course of the previous fall and spring. The camp site for the wilderness program is completely outdoors, with a canopy of hardwood forest providing much of the shelter. Further investigation identified an earlier camp participant who had received a diagnosis of Lyme disease in 2017 (Table).

North Carolina has historically had a low incidence of reported Lyme disease cases (1) but remains the southernmost border of the leading edge of Lyme disease in the United States (2). In North Carolina in 2017, 0.69 confirmed cases of Lyme disease per 100,000 residents were reported, a rate significantly lower than the 2017 national average of 9.1 confirmed cases per 100,000 residents (3).

On June 13, a North Carolina interagency assessment team traveled to the wilderness day camp to conduct entomologic surveillance for Ixodes ticks. Participants covered a total of 0.27 acres (1,077 m2) of land while “flagging and dragging.”* A total of 39 nymphal ticks were collected. Ticks were preserved in 95% ethanol and sent to CDC’s Division of Vector-Borne Diseases in Fort Collins, Colorado, for pathogen testing. Of the 39 ticks collected, 37 (95%) were confirmed as Ixodes scapularis ticks by molecular testing. Two ticks yielded poor DNA, and pathogen tests were ruled inconclusive. Six of the 35 ticks yielding DNA suitable for analysis tested positive for B. burgdorferi sensu stricto, the causative agent of Lyme disease. One of the six ticks was coinfected with Borrelia miyamotoi. All 35 ticks tested negative for Anaplamsa phagocytophilum and Babesia microti (two pathogens tested for when conducting Ixodes tick testing). Results indicated that nymphal ticks collected at the camp site had a B. burgdorferi infection prevalence of 17% (95% confidence interval = 8.1–32.7).

This was the first reported cluster of Lyme disease patients with a common exposure to be identified in North Carolina and the furthest south that Borrelia-infected ticks have been identified through North Carolina Division of Public Health entomologic surveillance efforts. Clinicians should be aware of the risk for transmission of Lyme disease in North Carolina and consider recommended diagnostic testing and treatment (4). To prevent exposure to Borrelia and other tickborne diseases, North Carolina Division of Public Health encourages everyone to wear personal protective clothing, to use EPA-approved repellents such as diethyltoluamide (DEET), and to conduct full-body examinations for ticks following outdoor activities in possible tick habitats. Prevention is the best defense against Lyme disease. Close collaboration between the North Carolina Division of Public Health and county health departments, along with clinician awareness, are essential for rapid identification of vector-borne disease expansion and appropriate treatment.

Corresponding author: Alexis M. Barbarin, alexis.barbarin@dhhs.nc.gov, 919-546-1623.


1Communicable Disease Branch, North Carolina Division of Public Health, North Carolina Department of Health and Human Services, Raleigh, North Carolina; 2Southern Appalachian Environmental Research and Education Center and Department of Biology, Appalachian State University, Boone, North Carolina; 3Buncombe County Health and Human Services, Asheville, North Carolina.

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.


* To sample the environment for ticks trying to locate a host, light-colored cloths with a wooden leading frame are dragged through grass or a leafy forest floor (dragging), and light colored cloths are used to brush uneven surfaces such as small bushes in wooded areas (flagging).

References

  1. CDC. Lyme disease: data and surveillance. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/lyme/datasurveillance/index.html
  2. Lantos PM, Nigrovic LE, Auwaerter PG, et al. Geographic expansion of Lyme disease in the southeastern United States, 2000–2014. Open Forum Infect Dis 2015;2:ofv143. CrossRef PubMed
  3. CDC. National notifiable infectious diseases and conditions: United States, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://wonder.cdc.gov/nndss/static/2017/annual/2017-table1.html
  4. Wright WF, Riedel DJ, Talwani R, Gilliam BL. Diagnosis and management of Lyme disease. Am Fam Physician 2012;85:1086–93. PubMed
TABLE. Demographic information and clinical and laboratory evidence of Lyme disease in four attendees at a wilderness day camp — North Carolina, 2017 and 2019Return to your place in the text
Patient Age (yrs) Sex Date of illness onset Clinical evidence Laboratory evidence Tick exposure Treatment Case classification
A 8 Female May 12, 2019 Brief, recurrent attacks of joint swelling Positive Borrelia burgdorferi IgG western blot Attended wilderness day camp Doxycycline Confirmed
Arthralgia Positive B. burgdorferi IgM western blot Ticks removed
Physician diagnosis of Lyme disease
B 6 Female May 1, 2019 Erythema migrans rash Negative B. burgdorferi IgG western blot Attended wilderness day camp Doxycycline Confirmed
Fever Positive B. burgdorferi IgM western blot Ticks removed
Headaches Positive Lyme disease antibody EIA, 1.77
Arthralgia
Loss of appetite
Increased fatigue
Physician diagnosis of Lyme disease
C 7 Male May 17, 2019 Small erythematous rash Negative B. burgdorferi IgG western blot Attended wilderness day camp Doxycycline Probable*
Fever Positive B. burgdorferi IgM western blot Ticks removed
Headaches Positive Lyme disease antibody EIA, 3.26
Physician diagnosis of Lyme disease
D 9 Male September 28, 2017 Erythema migrans rash Positive B. burgdorferi IgG western blot Attended wilderness day camp Doxycycline Confirmed
Radiculoneuropathy Positive B. burgdorferi IgM western blot
Cranial neuritis (Bell’s palsy) Positive Lyme disease antibody EIA, 11.08
Arthralgia
Physician diagnosis of Lyme disease

Abbreviations: EIA = enzyme immunoassay; Ig = immunoglobulin.
* https://wwwn.cdc.gov/nndss/conditions/lyme-disease/case-definition/2017/.


Suggested citation for this article: Barbarin AM, Seagle SW, Creede S. Notes from the Field: Four Cases of Lyme Disease at an Outdoor Wilderness Camp — North Carolina, 2017 and 2019. MMWR Morb Mortal Wkly Rep 2020;69:114–115. DOI: http://dx.doi.org/10.15585/mmwr.mm6904a5.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In: PDF [77K]